Computed Tomography (CT) Market Size & Growth Forecast 2027–2036, By Segments (End-use, Technology, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Computed Tomography Market size was around USD 5.7 billion in 2026 and is slated to grow at a 7.51% CAGR from 2027 to 2036, exceeding USD 11.76 billion by 2036. The industry revenue for 2027 is assessed at USD 6.06 billion.
Get more details on this report
Request Free Sample ReportComputed Tomography (CT) Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to high installed imaging capacity, strong reimbursement frameworks, and consistently high CT usage across emergency care, oncology, cardiology, and trauma applications.
- Asia Pacific is growing at 9.04% CAGR due to expanding diagnostic imaging access, rising hospital infrastructure, and increasing demand for earlier diagnosis across urban and developing healthcare networks.
Segment Momentum
- Hospitals held 45.88% of the market in 2026 because they manage high patient volumes, emergency imaging requirements, and integrated diagnostic workflows that drive consistent CT system utilization and replacement demand.
- CBCT is the fastest-growing technology segment due to its suitability for specialized imaging environments where compact design, procedural convenience, and targeted imaging capabilities are increasingly valued.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing demand for advanced diagnostic imaging procedures.
- AI-enabled CT scanner advancements improving imaging accuracy and operational workflow efficiency.
- Expanding preventive healthcare and screening programs strengthening adoption of routine CT diagnostics.
Leading Market Participants
- Leading players in the computed tomography market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Shanghai United Imaging Healthcare Co., Ltd. (China), NeuroLogica Corporation (United States), Carestream Dental LLC (United States), Shenzhen Anke High-tech Co., Ltd. (China), Koning Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.7 billion
- 2027 Estimated Market Size: USD 6.06 billion.
- Projected Market Size: USD 11.76 billion by 2036
- Growth Forecast: 7.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | High-end Slice CT (Technology) | Oncology (Application)
- Emerging Opportunity Segment: Diagnostic Imaging Centers (End-use) | Cone Beam CT (CBCT) (Technology) | Oncology (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing demand for advanced diagnostic imaging procedures
The increasing burden of chronic diseases is strengthening demand for diagnostic imaging, supporting the computed tomography market as healthcare providers require detailed assessment of complex medical conditions. CT imaging enables clinicians to visualize internal structures and identify abnormalities across multiple areas of the body, making it valuable in the evaluation and management of conditions that require timely and accurate diagnosis. Growing diagnostic requirements associated with cardiovascular disorders, cancer, respiratory diseases, and other chronic conditions are also encouraging healthcare facilities to maintain access to advanced imaging capabilities.
AI-enabled CT scanner advancements improving imaging accuracy and operational workflow efficiency
Integration of artificial intelligence into CT imaging systems is creating new opportunities for the computed tomography market by supporting image reconstruction, interpretation, and workflow optimization. AI-based technologies can assist in reducing image noise, improving the visibility of clinically relevant features, and helping radiology teams manage imaging workloads more efficiently. Automated assistance in image analysis and protocol selection can also reduce repetitive tasks for healthcare professionals, while improved processing capabilities can support faster movement of patients through diagnostic imaging departments.
Expanding preventive healthcare and screening programs strengthening adoption of routine CT diagnostics
Greater emphasis on early disease detection and preventive healthcare is supporting wider utilization of imaging-based screening, contributing to the computed tomography market. Healthcare systems are increasingly focusing on identifying diseases at earlier stages, when appropriate intervention can be more effective, creating demand for diagnostic technologies capable of producing detailed internal images. CT can be incorporated into selected screening and preventive care pathways where cross-sectional imaging is clinically appropriate, while broader public awareness of early detection and expanding access to diagnostic services can increase the use of routine imaging examinations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases increasing demand for advanced diagnostic imaging procedures | 1.90% | High | North America, Europe | High | Near Term |
| AI-enabled CT scanner advancements improving imaging accuracy and operational workflow efficiency | 1.60% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding preventive healthcare and screening programs strengthening adoption of routine CT diagnostics | 1.20% | Moderate | Asia Pacific, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the computed tomography market in 2026, reflecting strong demand for advanced diagnostic imaging across hospitals, specialty clinics, and emergency-care settings. The region benefits from well-developed healthcare infrastructure, broad access to sophisticated imaging technologies, and continued emphasis on early diagnosis and clinical workflow efficiency. Ongoing modernization of imaging facilities and the adoption of technologies that improve image quality, scanning efficiency, and dose management further support regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, increasing diagnostic capacity, and improving access to advanced medical imaging across emerging healthcare systems. Rising healthcare expenditure, greater awareness of early disease detection, and growing hospital investment are encouraging the installation and upgrading of computed tomography systems. At the same time, increasing demand for efficient diagnostic services in densely populated markets is creating favorable conditions for broader adoption of advanced imaging technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic ImagingGermany prioritizes advanced computed tomography technologies that deliver high-resolution imaging with optimized radiation management. Hospitals and diagnostic centers in Germany continue upgrading imaging infrastructure to strengthen clinical efficiency and support complex diagnostic procedures.
France 🇫🇷
Hospital Imaging ModernizationFrance continues modernizing hospital imaging capabilities by incorporating advanced computed tomography equipment into routine diagnostic pathways. Healthcare providers in France focus on improving imaging efficiency, patient throughput, and multidisciplinary clinical decision-making.
Italy 🇮🇹
Diagnostic Capacity EnhancementItaly strengthens computed tomography adoption by upgrading diagnostic imaging infrastructure across hospitals and specialty care centers. Healthcare providers in Italy continue emphasizing reliable imaging performance and efficient clinical workflows to support diverse diagnostic applications.
Japan 🇯🇵
High-Resolution Clinical ImagingJapan continues emphasizing sophisticated computed tomography systems that support early diagnosis and specialized clinical care. Healthcare institutions in Japan increasingly adopt advanced imaging technologies designed to improve examination quality, workflow integration, and patient management.
South Korea 🇰🇷
Smart Imaging IntegrationSouth Korea expands the adoption of computed tomography systems through digitally connected healthcare facilities and advanced diagnostic services. Medical providers in South Korea increasingly integrate AI-assisted imaging tools to improve scan interpretation and operational efficiency.
United States 🇺🇸
Advanced Imaging DeploymentHealthcare providers in the U.S. continue investing in high-performance computed tomography systems that improve diagnostic accuracy and clinical workflow efficiency. Demand is supported by expanding applications in emergency care, oncology, cardiovascular imaging, and image-guided procedures.
Segment Leadership and Growth Trends
Computed Tomography (CT) Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Imaging Centers (Fastest-Growing Segment)
Hospitals held the largest share of the computed tomography (CT) market in 2026, accounting for 45.88% of the market, supported by their extensive role in diagnosing and managing complex medical conditions that require advanced imaging. Hospitals typically maintain comprehensive diagnostic infrastructure and handle a broad range of emergency, inpatient, and specialized procedures, sustaining strong demand for CT systems. Their continued emphasis on expanding diagnostic capabilities and improving clinical workflows further reinforces the position of hospitals as the leading end-use setting.
Diagnostic imaging centers are emerging as the fastest-growing end-use segment, driven by the increasing use of specialized outpatient imaging services and the growing need for accessible diagnostic facilities outside hospital environments. These centers can focus specifically on imaging procedures, supporting efficient patient throughput and convenient access to diagnostic examinations. The expansion of specialized imaging infrastructure, greater emphasis on timely diagnosis, and increasing utilization of advanced imaging technologies are contributing to their rapid adoption.
Technology Segment Analysis: High-end Slice CT (Largest Segment) vs Cone Beam CT (CBCT) (Fastest-Growing Segment)
High-end slice CT systems accounted for the largest share of the computed tomography (CT) market in 2026, with a 37.1% share, reflecting their importance in applications requiring detailed cross-sectional imaging and comprehensive diagnostic capabilities. Their ability to support high-quality visualization across complex examinations makes them particularly valuable in advanced clinical settings. Continued demand for sophisticated diagnostic imaging, combined with efforts to improve image quality and examination efficiency, supports the segment's leading position.
Cone beam CT (CBCT) represents the fastest-growing technology segment, supported by its increasing suitability for applications requiring three-dimensional imaging with specialized imaging configurations. Its adoption is being encouraged by growing demand for precise anatomical visualization and more application-specific diagnostic workflows. Broader integration of advanced imaging technologies across specialized clinical environments is further creating opportunities for CBCT as healthcare providers seek imaging solutions aligned with targeted diagnostic requirements.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Diagnostic Imaging Centers, Others | Hospitals | Diagnostic Imaging Centers |
| Technology | High-end Slice CT, Mid-end Slice CT, Low-end Slice CT, Cone Beam CT (CBCT) | High-end Slice CT | Cone Beam CT (CBCT) |
| Application | Oncology, Cardiology, Vascular, Neurology, Musculoskeletal, Others | Oncology | Oncology |
Competitive Landscape and Market Positioning
Key companies in the computed tomography (CT) market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Fujifilm Holdings Corporation (Japan)
6. Shanghai United Imaging Healthcare Co. Ltd. (China)
7. NeuroLogica Corporation (United States)
8. Carestream Dental LLC (United States)
9. Shenzhen Anke High-tech Co. Ltd. (China)
10. Koning Corporation (United States)
Capital allocation in medical diagnostics is experiencing a major pivot as R&D programs fund next-generation advancements in the computed tomography (CT) market. Heavy internal investment is targeted directly at photon-counting detector technology and deep-learning image reconstruction algorithms. By advancing beyond traditional scintillator crystals, these heavily funded engineering projects aim to achieve sub-millimeter diagnostic spatial resolution while drastically cutting radiation exposure, significantly improving clinical oncology and cardiovascular workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Fujifilm Holdings Corporation (Japan) | |||||||
| Shanghai United Imaging Healthcare Co. Ltd. (China) | |||||||
| NeuroLogica Corporation (United States) | |||||||
| Carestream Dental LLC (United States) | |||||||
| Shenzhen Anke High-tech Co. Ltd. (China) | |||||||
| Koning Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Royal Philips | Apr-26 | Royal Philips secured U.S. FDA 510(k) clearance for its AI-powered Spectral CT Verida scanner. This expansion of the company's spectral portfolio integrates deep learning image reconstruction with a dual-layer detector system, optimizing clinical workflows, boosting patient throughput, and enhancing image quality across diagnostic and interventional CT configurations. |
| GE HealthCare | Mar-26 | GE HealthCare obtained U.S. FDA 510(k) clearance for Photonova Spectra, its scalable photon-counting computed tomography platform. Utilizing Deep Silicon detector technology, the launch strengthens the company’s advanced imaging portfolio and addresses diverse diagnostic and high-precision clinical requirements in the emerging photon-counting CT segment. |
| Brainomix | Feb-26 | Brainomix launched its next-generation Brainomix 360 Stroke software, introducing AI-powered CT stroke detection capabilities. The platform automates the assessment of net water uptake biomarkers from CT scans, providing specialized clinical decision support tools to improve risk stratification and acute stroke care management. |
| Canon | Dec-25 | Canon executed the global commercial launch of its hybrid Alphenix 4D CT system integrated with the Aquilion ONE/INSIGHT Edition scanner following U.S. FDA clearance. The advanced system merges interventional angiography and high-resolution computed tomography capabilities into a unified suite to optimize clinical workflows during complex surgical procedures. |
| Siemens Healthineers | Dec-24 | Siemens Healthineers expanded its commercial photon-counting computed tomography portfolio to reinforce its competitive position in high-end medical imaging. The strategic investment scales production and expands the application of next-generation photon-counting detectors to deliver improved diagnostic performance and greater imaging precision. |
| NVIDIA | Jul-24 | NVIDIA introduced VISTA-3D NIM microservices to accelerate the deployment of AI-enabled computed tomography workflows. The technology optimizes automated organ and disease segmentation, strengthening the underlying software ecosystem and computational infrastructure used by medical imaging developers for automated CT image analysis. |
| Koning Health | Feb-24 | Koning Health secured regulatory clearance from the Federal Authority for Nuclear Regulation in the United Arab Emirates, establishing the company as the first provider of dedicated breast CT technology in the country. This regulatory milestone drives geographic expansion and introduces specialized 3D breast imaging infrastructure to the region. |
| GE HealthCare | Jan-24 | GE HealthCare acquired MIM Software, a specialist in medical imaging analysis software. The acquisition integrates AI-driven radiation oncology, radiotherapy, and diagnostic imaging workflow tools into GE HealthCare's digital portfolio, accelerating the clinical capabilities and automation of its advanced CT imaging software ecosystem. |
| Canon Medical Systems Corp. | Nov-23 | Canon Medical Systems Corp. expanded its CT diagnostic footprint by unveiling two computed tomography scanners at RSNA. The launch introduced the high-throughput Aquilion Serve SP system alongside the new flagship Aquilion ONE/INSIGHT Edition, aimed at optimizing operating efficiency and increasing spatial resolution for healthcare providers. |
| GE HealthCare | Jan-23 | GE HealthCare reached an agreement to acquire France-based medical technology developer IMACTIS. The acquisition adds innovative CT interventional guidance systems to GE HealthCare’s portfolio, enhancing operational workflows and precision targeting for minimally invasive interventional CT procedures across diverse healthcare settings. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Computed Tomography (CT) Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Type | Adult, Pediatric, Geriatric |
| Procurement Model | Direct Purchase, Leasing, Managed Equipment Services |
| Workflow Integration | Standalone Systems, PACS/RIS-Integrated Systems, Enterprise Imaging-Integrated Systems |
Computed Tomography (CT) Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| AI-Enabled CT Adoption Benchmarking |
|
| CT Equipment Replacement Cycle Analysis |
|
| CT Market Access and Reimbursement Readiness |
|
Need a different cut of the data?
Request Custom ResearchHow much is the computed tomography market worth?
How is the computed tomography industry projected to perform over the next decade?
Why is AI becoming a key purchasing consideration in the computed tomography (CT) market?
How are preventive healthcare programs influencing demand in the computed tomography (CT) market?
Why do hospitals account for the largest share of the computed tomography (CT) market?
What is driving the rapid growth of Cone Beam CT (CBCT) in the computed tomography market?
Why does North America hold the largest share in the CT market?
What is driving CT market growth in Asia Pacific?
What are the key competitors in the computed tomography landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization